» Authors » E H Niks

E H Niks

Explore the profile of E H Niks including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 26
Citations 650
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Ikelaar N, Barnard A, Eng S, Hosseini Vajargah S, Ha K, Kan H, et al.
medRxiv . 2024 Aug; PMID: 39148831
Serum biomarkers are promising minimally invasive outcome measures in clinical studies in Duchenne muscular dystrophy (DMD). However, biomarkers strongly associated with clinical progression and predicting performance decline are lacking. In...
2.
van de Velde N, Krom Y, Bongers J, Hoek R, Ikelaar N, van der Holst M, et al.
J Neuromuscul Dis . 2024 Jul; 11(5):1095-1109. PMID: 39031379
Background: Duchenne and Becker muscular dystrophy lack curative treatments. Registers can facilitate therapy development, serving as a platform to study epidemiology, assess clinical trial feasibility, identify eligible candidates, collect real-world...
3.
Koeks Z, Janson A, Beekman C, Signorelli M, van Duyvenvoorde H, van den Bergen J, et al.
Sci Rep . 2021 Mar; 11(1):5952. PMID: 33723284
Becker muscular dystrophy (BMD) is the milder allelic variant of Duchenne muscular dystrophy, with higher dystrophin levels. To anticipate on results of interventions targeting dystrophin expression it is important to...
4.
Catapano F, Scaglioni D, Maresh K, Ala P, Domingos J, Selby V, et al.
Epigenomics . 2020 Nov; 12(21):1899-1915. PMID: 33215544
To perform cross-sectional and longitudinal miRNA profiling in plasma from Duchenne muscular dystrophy (DMD) subjects and find non-invasive biomarkers in DMD. Plasma was collected from 14 age and sex matched...
5.
Bekooij T, Gilhuis H, Dawson L, Niks E
J Neuromuscul Dis . 2019 Dec; 7(1):47-50. PMID: 31868676
In an minority of Myasthenia Gravis (MG) patients, the autoantibodies bind to muscle-specific kinase (MUSK). These MuSK antibody-mediated MG (MuSK MG) patients are not only immunologically distinct, but also have...
6.
Ricotti V, Selby V, Ridout D, Domingos J, Decostre V, Mayhew A, et al.
Neuromuscul Disord . 2019 Mar; 29(4):261-268. PMID: 30852071
The field of translational research in Duchenne muscular dystrophy (DMD) has been transformed in the last decade by a number of therapeutic targets, mostly studied in ambulant patients. A paucity...
7.
de Mol C, Wong Y, van Pelt E, Ketelslegers I, Bakker D, Boon M, et al.
J Neurol . 2018 Mar; 265(6):1310-1319. PMID: 29569176
Introduction: Acquired demyelinating syndromes (ADS) are immune-mediated demyelinating disorders of the central nervous system in children. A nationwide, multicentre and prospective cohort study was initiated in the Netherlands in 2006,...
8.
Lourbakos A, Yau N, de Bruijn P, Hiller M, Kozaczynska K, Jean-Baptiste R, et al.
Sci Rep . 2017 Dec; 7(1):17888. PMID: 29263366
Duchenne Muscular Dystrophy (DMD) is a severe muscle disorder caused by lack of dystrophin. Predictive biomarkers able to anticipate response to the therapeutic treatments aiming at dystrophin re-expression are lacking....
9.
Hooijmans M, Doorenweerd N, Baligand C, Verschuuren J, Ronen I, Niks E, et al.
PLoS One . 2017 Aug; 12(8):e0182086. PMID: 28763477
Objectives: To assess the changes in phosphodiester (PDE)-levels, detected by 31P magnetic resonance spectroscopy (MRS), over 24-months to determine the potential of PDE as marker for muscle tissue changes in...
10.
Hooijmans M, Niks E, Burakiewicz J, Anastasopoulos C, van den Berg S, van Zwet E, et al.
Neuromuscul Disord . 2017 Mar; 27(5):458-464. PMID: 28302391
The progressive replacement of muscle tissue by fat in Duchenne muscular dystrophy (DMD) has been studied using quantitative MRI between, but not within, individual muscles. We studied fat replacement along...